These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3031148)

  • 41. Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.
    Kovacsovics TJ; Peitsch MC; Kress A; Isliker H
    J Immunol; 1987 Mar; 138(6):1864-70. PubMed ID: 3029222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assignment of the complement serine protease genes C1r and C1s to chromosome 12 region 12p13.
    Nguyen VC; Tosi M; Gross MS; Cohen-Haguenauer O; Jegou-Foubert C; de Tand MF; Meo T; Frézal J
    Hum Genet; 1988 Apr; 78(4):363-8. PubMed ID: 2834284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and regulation of C1 inhibitor in human skin fibroblasts.
    Katz Y; Strunk RC
    J Immunol; 1989 Mar; 142(6):2041-5. PubMed ID: 2537870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dissociation of C1 and concentration dependence of its activation kinetics.
    Kilchherr E; Fuchs H; Tschopp J; Engel J
    Mol Immunol; 1982 May; 19(5):683-91. PubMed ID: 6287243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kinetics of activation of the first component of complement (C1) by IgG oligomers.
    Tschopp J
    Mol Immunol; 1982 May; 19(5):651-7. PubMed ID: 6287242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.
    Ziccardi RJ
    J Immunol; 1982 Jun; 128(6):2500-4. PubMed ID: 6281332
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human complement subcomponent C2: purification and proteolytic cleavage in fluid phase by C1s, C1r2-C1s2 and C1.
    Thielens NM; Villiers MB; Reboul A; Villiers CL; Colomb MG
    FEBS Lett; 1982 May; 141(1):19-24. PubMed ID: 6282646
    [No Abstract]   [Full Text] [Related]  

  • 48. Recombinant human complement subcomponent C1s lacking beta-hydroxyasparagine, sialic acid, and one of its two carbohydrate chains still reassembles with C1q and C1r to form a functional C1 complex.
    Luo C; Thielens NM; Gagnon J; Gal P; Sarvari M; Tseng Y; Tosi M; Zavodszky P; Arlaud GJ; Schumaker VN
    Biochemistry; 1992 May; 31(17):4254-62. PubMed ID: 1533159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A molecular mechanism for the activation of the first component of complement by immune complexes.
    Schumaker VN; Hanson DC; Kilchherr E; Phillips ML; Poon PH
    Mol Immunol; 1986 May; 23(5):557-65. PubMed ID: 3018553
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformation and restricted segmental flexibility of C1, the first component of human complement.
    Poon PH; Schumaker VN; Phillips ML; Strang CJ
    J Mol Biol; 1983 Aug; 168(3):563-77. PubMed ID: 6310124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.
    Perkins SJ
    Biochem J; 1985 May; 228(1):13-26. PubMed ID: 2988513
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complement factor I and cofactors in control of complement system convertase enzymes.
    Sim RB; Day AJ; Moffatt BE; Fontaine M
    Methods Enzymol; 1993; 223():13-35. PubMed ID: 8271948
    [No Abstract]   [Full Text] [Related]  

  • 54. Reply to Mortensen et al.: The zymogen form of complement component C1.
    Almitairi JOM; Venkatraman Girija U; Furze CM; Simpson-Gray X; Badakshi F; Marshall JE; Schwaeble WJ; Mitchell DA; Moody PCE; Wallis R
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3867-E3868. PubMed ID: 29654143
    [No Abstract]   [Full Text] [Related]  

  • 55. Models of the complement C1 complex.
    Mortensen SA; Sander B; Jensen RK; Pedersen JS; Golas MM; Thiel S; Andersen GR
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3866. PubMed ID: 29654144
    [No Abstract]   [Full Text] [Related]  

  • 56. The structure and function of the first component of complement: genetic engineering approach (a review).
    Gál P; Cseh S; Schumaker VN; Závodszky P
    Acta Microbiol Immunol Hung; 1994; 41(4):361-80. PubMed ID: 7866721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.
    Bensa JC; Reboul A; Colomb MG
    Biochem J; 1983 Nov; 216(2):385-92. PubMed ID: 6318736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Classical complement pathway components C1r and C1s: purification from human serum and in recombinant form and functional characterization.
    Rossi V; Bally I; Lacroix M; Arlaud GJ; Thielens NM
    Methods Mol Biol; 2014; 1100():43-60. PubMed ID: 24218249
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complement components, C1 activation and disease activity in SLE.
    Sturfelt G; Sjöholm AG; Svensson B
    Int Arch Allergy Appl Immunol; 1983; 70(1):12-8. PubMed ID: 6293980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.